Bernstein
3 reasons Bernstein strategists are bullish on the EU pharma sector into 2025 By Investing.com
Investing.com — Bernstein analysts are optimistic about the European pharmaceutical sector as it heads into 2025, despite concerns over policy changes…
Read More »This European sector has a positive outlook under Trump 2.0, Bernstein says By Investing.com
Investing.com — The European defense sector is positioned for growth under a potential second term of Donald Trump, according to…
Read More »10 key investor questions on MicroStrategy stock answered by Bernstein By Investing.com
Investing.com — In a Tuesday note to clients, Bernstein analysts addressed ten key investor questions about MicroStrategy (NASDAQ: MSTR), highlighting…
Read More »Google faces a possible $100 billion litigation avalanche, says Bernstein
A federal judge ruled last month that Google is a monopolist, and on top of the penalties yet to come,…
Read More »